Assyro AI

Orange Book product · Generic (ANDA)

ETHACRYNATE SODIUM

ETHACRYNATE SODIUM

Generic (ANDA)ANDA 205473TE APRX PH HEALTH

At a glance

Jul 29, 2015

Approved

Generic (ANDA)

Application

AP

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 29, 2015

    11 yr 1 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ETHACRYNATE SODIUM

Strength

EQ 50MG BASE/VIAL

Dosage form

INJECTABLE

Route

INJECTION

TE code

AP

Application

ANDA 205473

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ETHACRYNATE SODIUM

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.